title: Dynamic susceptibility contrast-enhanced perfusion MR imaging at 1.5 T predicts final infarct size in a rat stroke model.
abstract: The purpose of the present animal experiment was to determine whether source images from dynamic susceptibility contrast-enhanced perfusion weighted imaging (DSC-PWI) at a 1.5T MR scanner, performed early after photochemically induced thrombosis (PIT) of cerebral middle artery (MCA), is feasible to predict final cerebral infarct size in a rat stroke model. Fifteen rats were subjected to PIT of proximal MCA. T2 weighted imaging (T2WI), diffusion-weighted imaging (DWI), and contrast-enhanced PWI were obtained at 1 h and 24 h after MCA occlusion. The relative lesion size (RLS) was defined as lesion volume/brain volume x 100% and measured for MR images, and compared with the final RLS on the gold standard triphenyl tetrazolium chloride (TTC) staining at 24 h. One hour after MCA occlusion, the RLS with DSC-PWI was 24.9 +/- 6.3%, which was significantly larger than 17.6 +/- 4.8% with DWI (P < 0.01). At 24 h, the final RLS on TTC was 24.3 +/- 4.8%, which was comparable to 25.1 +/- 3.5%, 24.6 +/- 3.6% and 27.9 +/- 6.8% with T2WI, DWI and DSC-PWI respectively (P > 0.05). The fact that at 1 h after MCA occlusion only the displayed perfusion deficit was similar to the final infarct size on TTC (P > 0.05) suggests that early source images from DSC-PWI at 1.5T MR scanner is feasible to noninvasively predict the final infarct size in rat models of stroke.
authors.affiliation: Department of Radiology, University Hospitals, K.U.LEUVEN, Herestraat 49, B-3000 Leuven, Belgium.
authors.forename: Feng
authors.initials: F
authors.lastname: Chen
authors.forename: Yasuhiro
authors.initials: Y
authors.lastname: Suzuki
authors.forename: Nobuo
authors.initials: N
authors.lastname: Nagai
authors.forename: Ronald
authors.initials: R
authors.lastname: Peeters
authors.forename: Guy
authors.initials: G
authors.lastname: Marchal
authors.forename: Yicheng
authors.initials: Y
authors.lastname: Ni
mesh_terms: D000818:Animals; D001921:Brain / Q000473:pathology / Q000503:physiopathology; D002544:Cerebral Infarction / Q000175:diagnosis* / Q000503:physiopathology; D003287:Contrast Media / Q000008:administration & dosage*; D004195:Disease Models, Animal; D018450:Disease Progression; D020244:Infarction, Middle Cerebral Artery / Q000175:diagnosis* / Q000503:physiopathology; D018810:Magnetic Resonance Angiography / Q000379:methods*; D008280:Magnetics; D008297:Male; D015588:Observer Variation; D011237:Predictive Value of Tests; D051381:Rats; D017207:Rats, Sprague-Dawley; D013194:Staining and Labeling / Q000379:methods; D020521:Stroke / Q000175:diagnosis* / Q000503:physiopathology; D013778:Tetrazolium Salts; D013997:Time Factors
chemical_list: D003287:Contrast Media; D013778:Tetrazolium Salts; C009591:triphenyltetrazolium